Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Carl Zeiss Meditec AG
Age
50–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient informed of the consequences and constraints of the protocol and who has given his/her written informed consent
Man or woman, over 50 years of age
Healthy eyes with bilateral cataract requiring surgical treatment for both eyes
Bilateral regular corneal astigmatism (confirmed by topography measurement)
Only patients requiring intraocular lenses of a power comprised between sphere +0.0 and +28.0 dioptres and between a cylindrical range of +1.0 to +4.0D in both eyes will be able to participate in the trial.
Biometry measurement/cataract density compatible with the IOLMaster evaluation
Bilateral uncomplicated cataract surgery and implantation into capsular bag by injector
Assured follow-up examinations
You may not be if
Patients unable to meet the limitations of the protocol or likely of non cooperation during the trial,
Patients whose freedom is impaired by administrative or legal order,
Monophtalmic patient.
Previous ocular surgery, including corneal/refractive surgery,
Chronic or recurrent uveitis,
Acute ocular disease or external/internal infection,
Any kind of macular degeneration and impairment of retina (clinical diagnosis/OCT examination)
Diabetes with retinal changes,
Pseudoexfoliation syndrome
Pathologic myosis
Irregular astigmatism, especially keratoconus,
Endothelial corneal dystrophy
Glaucoma or IOP higher than 21mmHg under ocular hypertension treatment
Aniridia
Pseudophakia
Cornea guttata; keratoplasty
Amotio operation; anamnesis with vitreous surgery
Amblyopia
Intraocular tumours; endotamponade
Phlogistic intraocular processes or other pre-existing processes that permanently limit the best corrected visual acuity to \> 0.3 logMAR
Any other pathology or condition presenting, according to the investigator opinion, a risk for the patient